As a major co-factor of F-actin depolymerization, WD-repeat domain 1 (WDR1) affects the cellular microenvironment by cytoskeleton remodeling, thereby influencing cell molecular behavior. Our previous study showed that WDR1 activates YAP (Yes-associated protein) signaling in non-small-cell lung cancer (NSCLC) cells, but the mechanism remains unclear. We discovered that knockdown WDR1 in NSCLC cells decreased the expression of YAP and the nucleus-to-cytoplasm ratio. Disruption of cortical stress by drugs significantly inhibited YAP nuclear trafficking and enhanced YAP phosphorylation. In WDR1-knockdown NSCLC cells, inhibition of Hippo pathway reduced the nuclear exclusion of YAP and phosphorylated YAP. Our data suggest that WDR1-mediated cortical stress might be involved in regulating YAP signaling, thereby affecting the proliferation and migration of NSCLC cells.
RauskolbCSunSSunGPanYIrvineKD.Cytoskeletal tension inhibits Hippo signaling through an Ajuba-Warts complex.Cell2014; 158:143–56
3.
WiolandHGuichardBSenjuYMyramSLappalainenPJegouARomet-LemonneG.ADF/cofilin accelerates actin dynamics by severing filaments and promoting their depolymerization at both ends.Curr Biol2017;27:1956–77
4.
OkadaKBlanchoinLAbeHChenHPollardTDBamburgJR.Xenopus actin-interacting protein 1 (XAip1) enhances cofilin fragmentation of filaments by capping filament ends.J Biol Chem2002;277:43011–6
5.
OnoS.Regulation of actin filament dynamics by actin depolymerizing factor/cofilin and actin-interacting protein 1: new blades for twisted filaments.Biochemistry2003;42:13363–70
6.
YuanBZhangRHuJLiuZYangCZhangTZhangC.WDR1 promotes cell growth and migration and contributes to malignant phenotypes of non-small cell lung cancer through ADF/cofilin-mediated actin dynamics.Int J Biol Sci2018;14:1067–80
7.
LuxenburgCHellerEPasolliHAChaiSNikolovaMStokesNFuchsE.Wdr1-mediated cell shape dynamics and cortical tension are essential for epidermal planar cell polarity.Nat Cell Biol2015;17:592–604
8.
FengXDegeseMSIglesias-BartolomeRVaqueJPMolinoloAARodriguesMZaidiMRKsanderBRMerlinoGSodhiAChenQGutkindJS.Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry.Cancer Cell2014;25:831–45
9.
LowBCPanCQShivashankarGVBershadskyASudolMSheetzM.YAP/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth.FEBS Lett2014;588:2663–70
10.
MoyaIMHalderG.Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine.Nat Rev Mol Cell Biol2019;20:211–26
11.
TaniguchiKWuLWGrivennikovSIde JongPRLianIYuFXWangKHoSBBolandBSChangJTSandbornWJHardimanGRazEMaeharaYYoshimuraAZucman-RossiJGuanKLKarinM.A gp130-Src-YAP module links inflammation to epithelial regeneration.Nature2015;519:57–62
12.
GregorieffALiuYInanlouMRKhomchukYWranaJL.Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer.Nature2015;526:715–8
13.
FrumTMurphyTMRalstonA.HIPPO signaling resolves embryonic cell fate conflicts during establishment of pluripotency in vivo.Elife2018;7:e42298
14.
DebaugniesMSanchez-DanasARoriveSRaphaelMLiagreMParentMABrisebarreASalmonIBlanpainC.YAP and TAZ are essential for basal and squamous cell carcinoma initiation.EMBO Rep2018;19:e45809
15.
SulaimanAMcGarrySLiLJiaDOoiSAddisonCDimitroulakosJArnaoutANessimCYaoZJiGSongHGaddeSLiXWangL.Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states.Mol Oncol2018;12:423–40
16.
NiWYaoSZhouYLiuYHuangPZhouALiuJCheLLiJ.Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m(6)A reader YTHDF3.Mol Cancer2019;18:143
17.
ZhangZDuJWangSShaoLJinKLiFWeiBDingWFuPvan DamHWangAJinJDingCYangBZhengMFengXHGuanKLZhangL.OTUB2 promotes cancer metastasis via Hippo-independent activation of YAP and TAZ.Mol Cell2019;73:7–21.e7
18.
BoopathyGTKHongW.Role of Hippo pathway-YAP/TAZ signaling in angiogenesis.Front Cell Dev Biol2019;7:49
19.
MisraJRIrvineKD.The Hippo signaling network and its biological functions.Annu Rev Genet2018;52:65–87
20.
MengZMoroishiTGuanKL.Mechanisms of Hippo pathway regulation.Genes Dev2016;30:1–17
21.
ChanSWLimCJChenLChongYFHuangCSongHHongW.The Hippo pathway in biological control and cancer development.J Cell Physiol2011;226:928–39
22.
RodanGMartinTJ.Therapeutic approaches to bone diseases.Science2000;289:1508–14
23.
EstarasCBennerCJonesKA.SMADs and YAP compete to control elongation of beta-catenin: LEF-1-recruited RNAPII during hESC differentiation.Mol Cell2015;58:780–93
24.
ParkJJeongS.Wnt activated beta-catenin and YAP proteins enhance the expression of non-coding RNA component of RNase MRP in colon cancer cells.Oncotarget2015;6:34658–68
25.
KamachiYKondohH.Overlapping positive and negative regulatory elements determine lens-specific activity of the delta 1-crystallin enhancer.Mol Cell Biol1993;13:5206–15
26.
OtaMSasakiH.Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.Development2008;135:4059–69
27.
WadaKItogaKOkanoTYonemuraSSasakiH.Hippo pathway regulation by cell morphology and stress fibers.Development2011;138: 3907–14
28.
FletcherDAMullinsRD.Cell mechanics and the cytoskeleton.Nature2010;463:485–92
29.
HallA.The cytoskeleton and cancer.Cancer Metast Rev2009;28:5–14
30.
DupontSMorsutLAragonaMEnzoEGiulittiSCordenonsiMZanconatoFLe DigabelJForcatoMBicciatoSElvassoreNPiccoloS.Role of YAP/TAZ in mechanotransduction.Nature2011;474:179–212
31.
YangWHanWQinAWangZXuJQianY.The emerging role of Hippo signaling pathway in regulating osteoclast formation.J Cell Physiol2018;233:4606–17
ViteAZhangCYiREmmsSRadiceGL.alpha-Catenin-dependent cytoskeletal tension controls Yap activity in the heart.Development2018;145:dev149823
34.
YaoFXiaoZSunYMaL.SKP2 and OTUD1 govern non-proteolytic ubiquitination of YAP that promotes YAP nuclear localization and activity.Cell Stress2018;2:233–5
35.
CalsesPCCrawfordJJLillJRDeyA.Hippo pathway in cancer: aberrant regulation and therapeutic opportunities.Trends Cancer2019;5:297–307
36.
PobbatiAVHanXHungAWWeiguangSHudaNChenGYKangCBChiaCSBLuoXLHongWJPoulsenA.Targeting the central pocket in human transcription factor TEAD as a potential cancer therapeutic strategy.Structure2015;23:2076–86
37.
SmithBAGellesJGoodeBL.Single-molecule studies of actin assembly and disassembly factors.Methods Enzymol2014;540:95–117
38.
EspositoDPantIShenYQiaoRFYangXBBaiYYJinJPoulikakosPIAaronsonSA.ROCK1 mechano-signaling dependency of human malignancies driven by TEAD/YAP activation.Nat Commun2022;13:703
39.
PuJHuangYGFangQWangJCLiWCXuZMWuXJLuYWeiHM.Hypoxia-induced Fascin-1 upregulation is regulated by Akt/Rac1 axis and enhances malignant properties of liver cancer cells via mediating actin cytoskeleton rearrangement and Hippo/YAP activation.Cell Death Discov2021;7:385
40.
PiccoloSDupontSCordenonsiM.The biology of YAP/TAZ: Hippo signaling and beyond.Physiol Rev2014;94:1287–312
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
